Testing the first treatment to protect babies of asthmatic women from lung disease – a pilot study
Dr Kathryn Gatford
The University of Adelaide
Babies of mothers who have asthma are more likely to have problems breathing at birth, including respiratory distress syndrome. There are NO treatments available to protect babies of asthmatic women from neonatal lung problems. We have provided the first evidence that maternal asthma delays fetal lung maturation, and we will now use our pre-clinical model to test whether a clinically-used therapy to promote lung maturation protects babies of asthmatic mothers from neonatal lung disease. If this therapy is effective, it will reduce the numbers of Australian babies requiring admission to special care or neonatal intensive care units by 945-1075 /year.